Instituto Joinvilense de Hematologia e Oncologia (Site 0308)

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Lung cancer

Closed trials

• Completed

  Study of Pembrolizumab (MK-3475) Subcutaneous (SC) Versus Pembrolizumab Intravenous (IV) Administered With Platinum Doublet Chemotherapy in Participants With Metastatic Squamous or Nonsquamous Non-Small Cell Lung Cancer (NSCLC) (MK-3475-A86)

  NCT04956692· Phase 3· Merck Sharp & Dohme LLC· Source